Search research articles
Contact Us
Filters
Showing results (11-20 of 341) with videos related to
Page
of 35
Sort By:
The Practitioner
|
June 1, 1981
Tumour markers. Their role in clinical medicine
D P Dearnaley, R C Coombes
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1996
Multiple forms of TGF-beta 1 in breast tissues: a biologically active form of the small latent complex of TGF-beta 1
R Baillie, R C Coombes, J Smith
BMJ (Clinical Research Ed.)
|
September 19, 2000
Tumour markers in malignancies. Two isoforms of oestrogen receptor are now known to exist
C Palmieri, S Fishpool, R C Coombes
Oncology
|
April 1, 1993
Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas
C Topham, J Glees, R C Coombes
Cancer Treatment and Research
|
January 1, 1988
Aromatase inhibitors as new endocrine therapy for breast cancer
A M Brodie, M Dowsett, R C Coombes
The British Journal of Surgery
|
June 17, 2003
Letter 1: Bone marrow micrometastasis in breast cancer (Br J Surg 2003; 90: 290-301)
A Singh, M J Slade, R C Coombes
Endocrinology
|
July 1, 1986
1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor
K Colston, J R Wilkinson, R C Coombes
The Journal of Steroid Biochemistry and Molecular Biology
|
September 1, 1992
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients
M Dowsett, R C Stein, R C Coombes
British Journal of Cancer
|
August 1, 1992
Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues
Y A Luqmani, M Graham, R C Coombes
Endocrine-Related Cancer
|
March 24, 2000
Aromatase inhibitors and their use in the sequential setting
R C Coombes, C Harper-Wynne, M Dowsett
Page
of 35
Search research articles
Search
Showing results (11-20 of 341) with videos related to
Sort By:
Page
of 35
The Practitioner
|
June 1, 1981
Tumour markers. Their role in clinical medicine
D P Dearnaley, R C Coombes
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1996
Multiple forms of TGF-beta 1 in breast tissues: a biologically active form of the small latent complex of TGF-beta 1
R Baillie, R C Coombes, J Smith
BMJ (Clinical Research Ed.)
|
September 19, 2000
Tumour markers in malignancies. Two isoforms of oestrogen receptor are now known to exist
C Palmieri, S Fishpool, R C Coombes
Oncology
|
April 1, 1993
Comparison of single-agent epirubicin and 5-fluorouracil/epirubicin/mitomycin in patients with advanced adenocarcinoma of the pancreas
C Topham, J Glees, R C Coombes
Cancer Treatment and Research
|
January 1, 1988
Aromatase inhibitors as new endocrine therapy for breast cancer
A M Brodie, M Dowsett, R C Coombes
The British Journal of Surgery
|
June 17, 2003
Letter 1: Bone marrow micrometastasis in breast cancer (Br J Surg 2003; 90: 290-301)
A Singh, M J Slade, R C Coombes
Endocrinology
|
July 1, 1986
1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor
K Colston, J R Wilkinson, R C Coombes
The Journal of Steroid Biochemistry and Molecular Biology
|
September 1, 1992
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients
M Dowsett, R C Stein, R C Coombes
British Journal of Cancer
|
August 1, 1992
Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues
Y A Luqmani, M Graham, R C Coombes
Endocrine-Related Cancer
|
March 24, 2000
Aromatase inhibitors and their use in the sequential setting
R C Coombes, C Harper-Wynne, M Dowsett
Page
of 35